Low-dose interleukin-2 treatment selectively modulates CD4+ T cell subsets in patients with systemic lupus erythematosusJing He, Zhanguo Li, Yaping Chen et al.|Nature Medicine|2016Cited by 570
Combined therapy of prednisone and mTOR inhibitor sirolimus for treating retroperitoneal fibrosisHui Gao, Cuiping Pan, Shibo Liu et al.|Annals of the Rheumatic Diseases|2023Cited by 24